Latest updates for Htgc
Fresh curated links around HTGC are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Hercules Capital: Buy The Dip On This 12% BDC Yield
- Is First Trust's FTGC Commodities ETF a Buy After Climber Capital Purchased Shares Worth $3.8 Million?
- BDCs' Path Hinges On This
Post angles to try
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Is First Trust's FTGC Commodities ETF a Buy After Climber Capital Purchased Shares Worth $3.8 Million?
This ETF employs an actively managed strategy to provide diversified commodity exposure with daily liquidity and transparency for investors.
HCG Q4 PAT drops 70% to ₹2.17 crore; revenue rises 11%
Revenue for the quarter at ₹650.29 crore
Arvest Adds $3.1 Million Position in FTGC ETF
This ETF targets diversified global commodities with an active strategy, balancing income generation and inflation protection for investors.
Centennial Wealth Advisory Builds Stake in First Trust Growth Strength ETF, According to Recent SEC Filing
The First Trust Growth Strength ETF (FTGS) filters growth stocks through financial strength screens instead of tracking the full growth universe. That distinction tends to stand ou...
TG Therapeutics: Flawless Execution And $500 Million Non-Dilutive Capital Bolster Outlook
Buy this Canadian microcap for a double, analyst says
Beacon Securities analyst Russell Stanley maintained his $0.30 target on Thermal Energy International (Thermal Energy International Stock Quote, Chart, News, Analysts, Financials T...
This $4 Million Bet Shows Growing Confidence in 10x Genomics as Stock Surges 116%
10x Genomics provides advanced tools for single cell and spatial biology research, serving academic and biopharma institutions worldwide.
This $4 Million Bet Shows Growing Confidence in 10x Genomics as Stock Surges 116%
10x Genomics provides advanced tools for single cell and spatial biology research, serving academic and biopharma institutions worldwide.
Hims & Hers: Bargain EBITDA Multiples As GLP-1 Drama Passes
Buy this pot stock for a double, analyst says
Roth Capital analyst Bill Kirk maintained a “Buy” rating and $5.00 target on High Tide (High Tide Stock Quote, Chart, News, Analysts, Financials NASDAQ:HITI), citing record Remexia...
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.